PUBLISHER: Allied Market Research | PRODUCT CODE: 1266338
PUBLISHER: Allied Market Research | PRODUCT CODE: 1266338
The fluid management devices market valued for $4,563.00 million in 2021 and is estimated to reach $13,292.76 million by 2031, exhibiting a CAGR of 11.3% from 2022 to 2031.
The fluid management devices are used to improve visibility during surgical procedures or endoscopic surgeries by providing precise fluid pressure to internal cavities. This system is used for various types of surgeries, including hysteroscopy, laparoscopy, and others. It consists of a collection system, a pump, a controller, and a monitor. The collection system is used to collect fluids during the procedure and the pump is used to move the fluid from the collection system to the controller. The controller is used to regulate the flow of fluid and the monitor is used to monitor the fluid levels. The system is designed to help reduce the risk of infection and to improve the accuracy of surgical procedures. Fluid management devices is used in different types of minimally invasive surgeries such as arthroscopy, laparoscopy, hysteroscopy, and others.
The growth of the fluid management devices market is driven by technological advancement for development of different fluid management devices and rise in prevalence of chronic diseases as gastroesophageal reflux disease, enlarged prostate bladder tumor, bladder cancer, colorectal cancer, endometrial cancer, and others. Rise in the prevalence of chronic diseases cause increase in the number of surgical procedures for diagnosis and treatment purpose. Thus, this factor is anticipated to drive the demand for fluid management devices in surgical procedures and boosts the market growth. In addition, rise in prevalence endometrial cancer cause, surge the demand for hysteroscopic surgeries. Thus, this factor is anticipated to fuel the usage of fluid management devices and anticipated to drive the growth of the market. For instance, according to the American Cancer Society, it was reported that in 2023, estimated cases for uterine cancer are 66,200. In addition, in 2020, according to the World Cancer Research Fund International (WCRF), it was reported that around 417,367 female population was diagnosed with endometrial cancer across the globe. This factor is anticipated to drive the number of hysteroscopy and fuels the demand for fluid management devices. Therefore, rise in number of endometrial cancers is attributed to boost the growth of market.
In addition, increase in the product launch and product approval for different fluid management devices is anticipated to drive the growth of market. Moreover, growing prevalence of musculoskeletal disorders, such as osteoarthritis and rheumatoid arthritis cause rise in the number of arthroscopic surgical procedures. In addition, increasing geriatric population is also contributing to the rise in number of arthroscopic procedures, as older adults are more prone to musculoskeletal disorders. Also, technological advancements in arthroscopy devices and increasing awareness about their advantages cause an increase in surgical interventions. Thus, this factor is anticipated to increase the demand for fluid management devices and boost the growth of the market.
Moreover, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, as per the Office for National Statistics, in 2021, it was reported that total healthcare expenditure in the UK was $300,07 billion, which is an increase in nominal terms of 7.4% on spending in 2020. Moreover, according to Centers for Medicare and Medical Services Government (CMS), it was reported that, national healthcare expenditure (NHE) grew by 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP). Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for fluid management devices in hospitals, clinics diagnostic centers and others, thereby boosting the market growth.
On the other hand, the major restraint for the fluid management devices market is the potential risks associated with the procedures, such as infection, bleeding, and tissue damage. Additionally, the cost of treatment and lack of trained professionals are hindering the growth of the market.
The fluid management devices market is segmented into product, application, end user and region. Based on product, the market is divided into fluid management devices and fluid management accessories. Based on application, the market is bifurcated into urology, hysteroscopy, laparoscopy, arthroscopy, and others. Based on end user, the market segmented hospitals, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global fluid management devices market include: Conmed corporation, Olympus Corporation, Baxter international Inc., Fresenius Medical Care, Stryker Corporation, Medtronic Plc., Karl Storz se and Co. KG., Cardinal Health, Bonvisi, and Hologic Inc.